CD4 and neoplasm: Notably, this therapeutic combination gave rise to a population of tumor-infiltrating CD4+ T cells with high expression of IFN-γ and TNF-α in response to re-stimulation with tumor antigens, suggesting that these cells were potent tumor antigen-specific Th1 cells (51).